start portlet menu bar

การขอดูเนื้อหาบนเว็บ

Display portlet menu
end portlet menu bar

Vaccination with the mixed administration of ERYSENG® PARVO and UNISTRAIN® PRRS in gilts clinically protects against a heterologous PRRSV infection

หน้าหลัก ความรู้ Vaccination with the mixed administration of ERYSENG® PARVO and UNISTRAIN® PRRS in gilts clinically protects against a heterologous PRRSV infection

Vaccination with the mixed administration of ERYSENG® PARVO and UNISTRAIN® PRRS in gilts clinically protects against a heterologous PRRSV infection

The clinical protection provided by the combined administration of ERYSENG® PARVO and UNISTRAIN® PRRS against the Porcine Reproductive Respiratory Syndrome (PRRS) in gilts was assessed in this study. Reproductive performance after a heterologous challenge was the main efficacy parameter.

เกี่ยวกับบทความ

ตามที่ปรากฎ

ESPHM Congress, 2015

ผู้แต่ง

Puig, A.; Fontseca, M.; Camprodon, A.; Miranda, J.; Sitjà, M.; March, R.

บทสรุป

The combined administration of ERYSENG® PARVO and UNISTRAIN® PRRS significantly reduced the number of weak piglets and the presence of mummies in vaccinated gilts after a heterologous PRRSV challenge. So the use of the vaccine mixture clinically protected gilts from a heterologous PRRSV infection. The results obtained allow the conclusion to be drawn, that efficacy in terms of clinical protection after a PRRS challenge with the combined use of the two vaccines is comparable to that of UNISTRAIN® PRRS administered alone.

บริการที่เกี่ยวข้อง

ผลิตภัณฑ์ที่เกี่ยวข้อง

แบ่งปัน